AN
Aion Therapeutic Inc.
ANTCF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $2.95M
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
75 /100
Cheap P/S 2.00x
P/E N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
15 /100
Weak Gross margin 37.50%
FCF margin 104.95%
Net margin 451.18%
Quality
79 /100
Excellent ROIC 82.47%
Asset turnover 1.22x
ROA 550.85%
Debt
0 /100
High Current ratio 0.19x
Int. coverage -19.07x
Debt/Equity N/A
Stability
1 /100
Unstable Beta 4.71x
Profitable years 0
EPS volatility 749.42%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ANTCF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
John Graham Simmonds Jr.
Employees
5
Headquarters
Vancouver